| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |